Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enveric Biosciences Inc (ENVB) vs Clear Secure Inc (YOU) Price & Performance

Enveric Biosciences IncTrade
Clear Secure IncTrade

Price performance (Past 24H)

Key statistics

Enveric Biosciences Inc vs Clear Secure Inc — how do they compare? Enveric Biosciences Inc trades at $1.37 (market cap $5.32M), while Clear Secure Inc trades at $54.61 (market cap $5.51B). The key difference: Clear Secure Inc is far larger — about 1035.7× Enveric Biosciences Inc's market cap, and Clear Secure Inc pays a 1.1% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.

ENVBYOU
Market Cap
$5.32M$5.51B
Sector
HealthTechnology
52-Week High
$17.40$62.36
52-Week Low
$1.28$28.84
Enterprise Value
$408.82K$4.82B
Dividend Yield
1.1%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Enveric Biosciences Inc

ENVB trades at $1.38, up 4.55% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported a net loss of $8.77M for 2025, though it beat EPS estimates in all four quarters. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003, including IND-enabling studies and positive preclinical results.

Outlook hinges on clinical progress, with 75% analyst buy ratings supporting potential upside, but high financial losses and negative ROE/ROA pose significant risks. Investors face volatility from regulatory developments and funding needs, making it speculative despite positive sentiment from recent operational updates.

Clear Secure Inc

Clear Secure (YOU) trades at $54.62, up 2.02% today, with a neutral technical signal and bullish moving averages. The company shows strong profitability with a 65.48% gross margin and 81.15% ROE, though valuations are elevated with a P/E of 43.72. Recent Q1 2026 earnings beat expectations, and expansion initiatives like the AWS integration and Indianapolis airport launch support growth. Cash flow improved to $83M net in 2026 from $18M in 2025.

The outlook is cautiously optimistic, with a consensus price target of $56.67 offering modest upside. Key opportunities include member growth and free cash flow strength, while risks involve high valuation multiples and competitive pressures. Analyst sentiment is balanced with 44% buy ratings, but execution on guidance remains critical for sustained momentum.

Returns comparison

Trailing returns across standard periods

About Enveric Biosciences Inc

Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.

Read more on ENVB

About Clear Secure Inc

Clear Secure operates a secure identity platform that uses biometrics—specifically eyes, face, and fingerprints—to automate and expedite identity verification. While its most visible application is the CLEAR Plus airport subscription service, the company functions as a broad-based identity layer for travel, healthcare, and digital services, aiming to replace physical IDs with a secure, biometric link.

Read more on YOU